<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0007">
 <label>7.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Dhama</surname>
    <given-names>K</given-names>
   </name>, 
   <name name-style="western">
    <surname>Karthik</surname>
    <given-names>K</given-names>
   </name>, 
   <name name-style="western">
    <surname>Khandia</surname>
    <given-names>R</given-names>
   </name>, 
   <name name-style="western">
    <surname>Chakraborty</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Munjal</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>Latheef</surname>
    <given-names>SK</given-names>
   </name>, 
   <name name-style="western">
    <surname>Kumar</surname>
    <given-names>D</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ramakrishnan</surname>
    <given-names>MA</given-names>
   </name>, 
   <name name-style="western">
    <surname>Malik</surname>
    <given-names>YS</given-names>
   </name>, 
   <name name-style="western">
    <surname>Singh</surname>
    <given-names>R</given-names>
   </name>, et al
  </person-group>
  <article-title>Advances in designing and developing vaccines, drugs, and therapies to counter Ebola virus</article-title>. 
  <source>Front Immunol</source>. 
  <year>2018</year>;
  <volume>9</volume>:
  <fpage>1803</fpage>. doi:
  <pub-id pub-id-type="doi">10.3389/fimmu.2018.01803</pub-id>.
  <pub-id pub-id-type="pmid">30147687</pub-id>
 </mixed-citation>
</ref>
